fbpx
Electronic prescription. Mobile E-prescription app. Doctor giving list of medicine to patient.

New Study Demonstrates Acceptability but Mixed Impacts of Mobile Health Interventions for Patients with...

Mobile health interventions are an acceptable approach that may improve adherence outcomes in patients with cancer, similar to findings in other chronic diseases, according to a review published recently in the Clinical Journal of...
Advertisement

Journal Reading List

Multiple Myeloma Knowledge Hub

Researchers Encourage Exploration of Dual-Targeted CAR T-Cell Treatment in Multiple Myeloma

Targeted immunotherapy is a very promising strategy in the treatment of multiple myeloma (MM). Specifically, clinical trials using chimeric antigen receptor (CAR) T-cells to...

Electroencephalography Useful for Seizure Detection in Children and Young Adults Receiving CAR T-Cell Therapy

Immune effector cell–associated neurotoxicity syndrome is a clinical and neuropsychiatric syndrome that can occur in the days to weeks following administration of certain types...

Research Group Publishes Recommendations on Infection in Patients Receiving CAR T-Cell Therapy

Chimeric antigen receptor (CAR) T-cell therapy is a rapidly emerging treatment option for patients with B-cell malignancies. Many patients who receive CAR T-cell therapy...
Doctor in blue gloves reads about Multiple myeloma.

Researchers Explore Safety and Efficacy of BCMA CAR T-Cell Therapy in Patients with Multiple...

Chimeric antigen receptor (CAR) T-cell immunotherapy has shown great promise against hematologic malignancies. Therefore, the treatment has become a robust area of current research...

Hem/Onc Roundup: ASCO Highlights, Plus Racial Disparities in Symptom Reporting

This week on DocWire, findings from CARTITUDE-1 found that ciltacabtagene autoleucel (cilta-cel), an anti-B cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T cell...
Nurse talking and doing a emotional support to a female senior patient at hospital

Supporting Bone Health in Patients Receiving Stem Cell Transplant

New guidelines from the International Osteoporosis Foundation (IOF) address management of osteoporosis, fracture risk, and overall bone health among patients receiving autologous hematopoietic cell...
FDA approved stamp

Melflufen Combination Approved for Heavily Pretreated Multiple Myeloma

On March 1, the U.S. Food and Drug Administration (FDA) granted accelerated approval to melphalan flufenamide (melflufen) in combination with dexamethasone for the treatment...

KarMMA: BCMA CAR-T Spurs Lasting Remission in Relapsed/Refractory MM

The latest updates from the KarMMA trial, published in The New England Journal of Medicine, showed that treatment with idecabtagene vicleucel (ide-cel) for relapsed/refractory...
Advertisement
Advertisement